References
- Altice, F. L., Kamarulzaman, A., Soriano, V. V., Schechter, M., & Friedland, G. H. (2010). Treatment of medical, psychiatric, and substance-use comorbidities in people infected with HIV who use drugs. The Lancet, 376(9738), 367–387. https://doi.org/https://doi.org/10.1016/S0140-6736(10)60829-X
- Azar, P., Wood, E., Nguyen, P., Luma, M., Montaner, J., Kerr, T., & Milloy, M.-J. (2015). Drug use patterns associated with risk of non-adherence to antiretroviral therapy among HIV-positive illicit drug users in a Canadian setting: A longitudinal analysis. BMC Infectious Diseases, 15(1), 193. https://doi.org/https://doi.org/10.1186/s12879-015-0913-0
- BC Coroners Service. (2018). Illicit drug overdose deaths in BC. https://www2.gov.bc.ca/assets/gov/birth-adoption-death-marriage-and-divorce/deaths/coroners-service/statistical/illicitdrugoverdosedeathsinbc-findingsofcoronersinvestigations-final.pdf
- B Leavitt, S., Shinderman, M., Maxwell, S., Eap, C., & Paris, P. (2000). When “enough” is not enough: New perspectives optimal methadone maintenance dose. The Mount Sinai journal of medicine, New York (Vol. 67).
- British Columbia Centre on Substance Use. (2019). Heroin compassion clubs. Retrieved March 7, 2019, from http://www.bccsu.ca/wp-content/uploads/2019/02/Report-Heroin-Compassion-Clubs.pdf
- British Columbia Coroners Service. (2018). Fentanyl-detected illicit drug overdose deaths. Retrieved November 1, 2018, from https://www2.gov.bc.ca/assets/gov/birth-adoption-death-marriage-and-divorce/deaths/coroners-service/statistical/fentanyl-detected-overdose.pdf
- Burnham, K., & Anderson, D. (2002). Model selection and multimodel inference: A practical information-theoretical approach (2nd ed). Springer US.
- Carroll, J. J., Marshall, B. D. L., Rich, J. D., & Green, T. C. (2017). Exposure to fentanyl-contaminated heroin and overdose risk among illicit opioid users in Rhode Island: A mixed methods study. The International Journal on Drug Policy, 46, 136–145. https://doi.org/https://doi.org/10.1016/j.drugpo.2017.05.023
- Centers for Disease Control and Prevention. (2019). Understanding the Epidemic. https://www.cdc.gov/drugoverdose/epidemic/index.html
- Centers for Disease Control and Prevention. (2020). HIV and Older Americans. Retrieved November 30, 2020, from https://www.cdc.gov/hiv/group/age/olderamericans/index.html
- Darke, S. (1998). Self-report among injecting drug users: A review. Drug and Alcohol Dependence, 51(3), 253–263. https://doi.org/https://doi.org/10.1016/S0376-8716(98)00028-3
- D’Aunno, T., Pollack, H. A., Frimpong, J. A., & Wutchiett, D. (2014). Evidence-based treatment for opioid disorders: A 23-year national study of methadone dose levels. Journal of Substance Abuse Treatment, 47(4), 245–250. https://doi.org/https://doi.org/10.1016/j.jsat.2014.06.001
- Donroe, J. H., Holt, S. R., & Tetrault, J. M. (2016). Caring for patients with opioid use disorder in the hospital. Canadian Medical Association Journal, 188(17–18), 1232–1239. https://doi.org/https://doi.org/10.1503/cmaj.160290
- Feelemyer, J., Des Jarlais, D., Arasteh, K., & Uusküla, A. (2015). Adherence to antiretroviral medications among persons who inject drugs in transitional, low and middle income countries: An international systematic review. AIDS and Behavior, 19(4), 575–583. https://doi.org/https://doi.org/10.1007/s10461-014-0928-3
- Ferri, M., Davoli, M., & Perucci, C. A. (2006). Heroin maintenance treatment for chronic heroin-dependent individuals: A Cochrane systematic review of effectiveness. Journal of Substance Abuse Treatment, 30(1), 63–72. https://doi.org/https://doi.org/10.1016/j.jsat.2005.09.003
- Gonzalez, A., Barinas, J., & Cleirigh, C. O. (2011). Substance Use : Impact on Adherence and HIV Medical Treatment, 223–234. https://doi.org/https://doi.org/10.1007/s11904-011-0093-5
- Government of BC. (2018). Lethal Drugs are Circulating. Retrieved July 25, 2018, from https://www2.gov.bc.ca/gov/content/overdose/lethal-drugs-are-circulating
- Government of Canada. (2018). National report: Apparent opioid-related deaths in Canada. Retrieved November 1, 2018, from https://www.canada.ca/en/public-health/services/publications/healthy-living/national-report-apparent-opioid-related-deaths-released-september-2018.html#a1
- Green, T. C., McGowan, S. K., Yokell, M. A., Pouget, E. R., & Rich, J. D. (2012). HIV infection and risk of overdose: A systematic review and meta-analysis. AIDS, 26(4), 403–417. https://doi.org/https://doi.org/10.1097/QAD.0b013e32834f19b6
- Haddad, N., Robert, A., Weeks, A., Popovic, N., Siu, W., & Archibald, C. (2018). 2018–HIV Surveillance Report. Retrieved November 30, 2020, from https://www.canada.ca/en/public-health/services/reports-publications/canada-communicable-disease-report-ccdr/monthly-issue/2019-45/issue-12-december-5-2019/article-1-2018-hiv-survellance-report.html
- Hanna, D. B., Buchacz, K., Gebo, K. A., Hessol, N. A., Horberg, M. A., Jacobson, L. P., Kirk, G. D., Kitahata, M. M., Korthuis, P. T., Moore, R. D., Napravnik, S., Patel, P., Silverberg, M. J., Sterling, T. R., Willig, J. H., Lau, B., Althoff, K. N., Crane, H. M., Collier, A. C., … Mendes, A. (2013). Trends and disparities in antiretroviral therapy initiation and virologic suppression among newly treatment-eligible HIV-infected individuals in North America, 2001-2009. Clinical Infectious Diseases, 56(8), 1174–1182. https://doi.org/https://doi.org/10.1093/cid/cit003
- Hayashi, K., Milloy, M.-J., Lysyshyn, M., DeBeck, K., Nosova, E., Wood, E., & Kerr, T. (2018). Substance use patterns associated with recent exposure to fentanyl among people who inject drugs in Vancouver, Canada: A cross-sectional urine toxicology screening study. Drug and Alcohol Dependence, 183, 1–6. https://doi.org/https://doi.org/10.1016/j.drugalcdep.2017.10.020
- Karamouzian, M., Papamihali, K., Graham, B., Crabtree, A., Mill, C., Kuo, M., Young, S., & Buxton, J. A. (2020). Known fentanyl use among clients of harm reduction sites in British Columbia, Canada. International Journal of Drug Policy, 77, 102665. https://doi.org/https://doi.org/10.1016/j.drugpo.2020.102665
- Krieger, M. S., Goedel, W. C., Buxton, J. A., Lysyshyn, M., Bernstein, E., Sherman, S. G., Rich, J. D., Hadland, S. E., Green, T. C., & Marshall, B. D. L. (2018). Use of rapid fentanyl test strips among young adults who use drugs. The International Journal on Drug Policy, 61, 52–58. https://doi.org/https://doi.org/10.1016/j.drugpo.2018.09.009
- Lake, S., Walsh, Z., Kerr, T., Cooper, Z. D., Buxton, J., Wood, E., Ware, M. A., Milloy, M. J., & Alegria, M. (2019). Frequency of cannabis and illicit opioid use among people who use drugs and report chronic pain: A longitudinal analysis. PLOS Medicine, 16(11), e1002967. https://doi.org/https://doi.org/10.1371/journal.pmed.1002967
- Layson-Wolf, C., Goode, J.-V., & Small, R. E. (2002). Clinical use of methadone. Journal Of Pain & Palliative Care Pharmacotherapy, 16(1), 29–59. http://proxy.lib.sfu.ca/login?url=https://search.ebscohost.com/login.aspx?direct=true&db=mnh&AN=14650449&site=ehost-live doi:https://doi.org/10.1080/J354v16n01_04
- Ledergerber, B. (2004). Predictors of trend in CD4-positive T-cell count and mortality among HIV-1-infected individuals with virological failure to all three antiretroviral-drug classes. The Lancet, 364(9428), 51–62. https://doi.org/https://doi.org/10.1016/S0140-6736(04)16589-6
- Lert, F., & Kazatchkine, M. D. (2007). Antiretroviral HIV treatment and care for injecting drug users: An evidence-based overview. The International Journal on Drug Policy, 18(4), 255–261. https://doi.org/https://doi.org/10.1016/j.drugpo.2007.05.002
- Lucas, G. M., Griswold, M., Gebo, K. A., Keruly, J., Chaisson, R. E., & Moore, R. D. (2006). Illicit drug use and HIV-1 disease progression: A longitudinal study in the era of highly active antiretroviral therapy. American Journal of Epidemiology, 163(5), 412–420. https://doi.org/https://doi.org/10.1093/aje/kwj059
- Macmadu, A., Carroll, J. J., Hadland, S. E., Green, T. C., & Marshall, B. D. L. (2017). Prevalence and correlates of fentanyl-contaminated heroin exposure among young adults who use prescription opioids non-medically. Addictive Behaviors, 68, 35–38. https://doi.org/https://doi.org/10.1016/j.addbeh.2017.01.014
- Mehta, S. H., Lucas, G., Astemborski, J., Kirk, G. D., Vlahov, D., & Galai, N. (2007). Early immunologic and virologic responses to highly active antiretroviral therapy and subsequent disease progression among HIV-infected injection drug users. AIDS Care, 19(5), 637–645. https://doi.org/https://doi.org/10.1080/09540120701235644
- Milloy, M. J., Kerr, T., Buxton, J., Rhodes, T., Guillemi, S., Hogg, R., Montaner, J., & Wood, E. (2011). Dose-response effect of incarceration events on nonadherence to HIV antiretroviral therapy among injection drug users. The Journal of Infectious Diseases, 203(9), 1215–1221. https://doi.org/https://doi.org/10.1093/infdis/jir032
- Montarroyos, U. R., Miranda-Filho, D. B., César, C. C., Souza, W. V., Lacerda, H. R., Militão Albuquerque, M. d. F. P., Aguiar, M. F., Ximenes, R. A. d. A., & Sluis-Cremer, N. (2014). Factors related to changes in CD4+ T-cell counts over time in patients living with HIV/AIDS: A multilevel analysis. PloS One, 9(2), e84276–e84276. https://doi.org/https://doi.org/10.1371/journal.pone.0084276
- Napper, L. E., Fisher, D. G., Johnson, M. E., & Wood, M. M. (2010). The reliability and validity of drug users’ self reports of amphetamine use among primarily heroin and cocaine users. Addictive Behaviors, 35(4), 350–354. https://doi.org/https://doi.org/10.1016/j.addbeh.2009.12.006
- National Academies of Sciences and Medicine, E. (2017). The health effects of cannabis and cannabinoids: The current State of evidence and recommendations for research. The National Academies Press. https://doi.org/https://doi.org/10.17226/24625
- Needle, R., Fisher, D. G., Weatherby, N., Chitwood, D., Brown, B., Cesari, H., Booth, R., Williams, M. L., Watters, J., Andersen, M., & Braunstein, M. (1995). Reliability of self-reported HIV risk behaviors of drug users. Psychology of Addictive Behaviors, 9(4), 242–250. https://doi.org/https://doi.org/10.1037/0893-164X.9.4.242
- Nosyk, B., Anglin, M. D., Brissette, S., Kerr, T., Marsh, D. C., Schackman, B. R., Wood, E., & Montaner, J. S. G. (2013). A call for evidence-based medical treatment of opioid dependence in the United States and Canada. Health Affairs, 32(8), 1462–1469. https://doi.org/https://doi.org/10.1377/hlthaff.2012.0846
- Park, J. N., Weir, B. W., Allen, S. T., Chaulk, P., & Sherman, S. G. (2018). Fentanyl-contaminated drugs and non-fatal overdose among people who inject drugs in Baltimore, MD. Harm Reduction Journal, 15(1): 34. https://doi.org/https://doi.org/10.1186/s12954-018-0240-z
- Reddon, H., DeBeck, K., Socias, M. E., Dong, H., Wood, E., Montaner, J., Kerr, T., & Milloy, M.-J. (2018). Cannabis use is associated with lower rates of initiation of injection drug use among street-involved youth: A longitudinal analysis. Drug and Alcohol Review, 37(3), 421–428. https://doi.org/https://doi.org/10.1111/dar.12667
- Ronald, P. J. M., Robertson, J. R., & Elton, R. A. (1994). Continued drug use and other cofactors for progression to AIDS among injecting drug users. AIDS. US: Lippincott Williams & Wilkins. https://doi.org/https://doi.org/10.1097/00002030-199403000-00007
- Silverstein, J. H., Rieders, M. F., McMullin, M., Schulman, S., & Zahl, K. (1993). An analysis of the duration of fentanyl and its metabolites in urine and saliva. Anesthesia and Analgesia, 76(3), 618–621. https://doi.org/https://doi.org/10.1213/00000539-199303000-00030
- Socías, M. E., Kerr, T., Wood, E., Dong, H., Lake, S., Hayashi, K., DeBeck, K., Jutras-Aswad, D., Montaner, J., & Milloy, M.-J. (2017). Intentional cannabis use to reduce crack cocaine use in a Canadian setting: A longitudinal analysis. Addictive Behaviors, 72, 138–143. https://doi.org/https://doi.org/10.1016/j.addbeh.2017.04.006
- Socías, M. E., Wood, E., Lake, S., Nolan, S., Fairbairn, N., Hayashi, K., Shulha, H. P., Liu, S., Kerr, T., & Milloy, M.-J. (2018). High-intensity cannabis use is associated with retention in opioid agonist treatment: A longitudinal analysis. Addiction, 113(12), 2250–2258. https://doi.org/https://doi.org/10.1111/add.14398
- Socías, M. E., Wood, E., McNeil, R., Kerr, T., Dong, H., Shoveller, J., Montaner, J., & Milloy, M.-J. (2017). Unintended impacts of regulatory changes to British Columbia methadone maintenance program on addiction and HIV-related outcomes: An interrupted time series analysis. The International Journal on Drug Policy, 45, 1–8. https://doi.org/https://doi.org/10.1016/j.drugpo.2017.03.008
- Strathdee, S. A., Palepu, A., Cornelisse, P. G., Yip, B., O'Shaughnessy, M. V., Montaner, J. S., Schechter, M. T., & Hogg, R. S. (1998). Barriers to use of free antiretroviral therapy in injection drug users. Journal of the American Medical Association, 280(6), 547–549. https://doi.org/https://doi.org/10.1001/jama.280.6.547
- Tupper, K. W., McCrae, K., Garber, I., Lysyshyn, M., & Wood, E. (2018). Initial results of a drug checking pilot program to detect fentanyl adulteration in a Canadian setting. Drug and Alcohol Dependence, 190(July), 242–245. https://doi.org/https://doi.org/10.1016/j.drugalcdep.2018.06.020
- Wiese, B., & Wilson-Poe, A. R. (2018). Emerging evidence for cannabis’ role in opioid Use disorder. Cannabis and Cannabinoid Research, 3(1), 179–189. https://doi.org/https://doi.org/10.1089/can.2018.0022